Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Higher DHT in male baldness may protect against prostate cancer.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Breast cancer may be detectable through changes in scalp hair lipids.

Low zinc levels may be linked to the return of gynecologic cancers.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Traditional Chinese Medicine and acupuncture may improve Polycystic Ovarian Syndrome symptoms and reduce costs, but more research is needed.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Resistance training improved BMI and menstrual regularity more in women with PCOS than aerobic training.

A woman's male-like physical changes were caused by two rare ovarian conditions.

A woman with PCOS successfully overcame secondary infertility and became pregnant with triplets after treatment.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.